A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People
Status:
TERMINATED
Trial end date:
2025-06-05
Target enrollment:
Participant gender:
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics and pharmacodynamics of BI 3731579 in healthy volunteers following administration of multiple rising doses per day over 15 days.